Nanjing King-Friend Biochemical Pharmaceutical Stock Forecast for 2023 - 2025 - 2030
Updated on 04/30/2024
Stock Rating
16
Price Target
¥20.19
Consensus
Outperform
Upside
45.15%
Analysts
0
Stock Rating
16
Upside
45.15%
Analysts
0
Price Target
¥20.19
Nanjing King-Friend Biochemical Pharmaceutical Stock Forecast and Price Target
Year-long price target forecasts from prominent analysts have recently been released for Nanjing King-Friend Biochemical Pharmaceutical, with an average price target of ¥20.19. This potential gain of 45.15 percent from the previous closing price in February, 2024 is calculated on a high forecast of ¥23.37 and a low estimate of ¥17.00. If you're looking for Nanjing King-Friend Biochemical Pharmaceutical (603707) stock information, you might also want to check out Livzon Pharmaceutical Group (SZSE:000513).
¥20.19
45.15% Upside
Buy
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF522.40 | Buy/Sell | CHF516.89 | 11.98% |
| 603259 Stock Forecast | WuXi AppTec | Buy |
18
|
¥44.57 | Buy/Sell | ¥121.48 | 50.93% |
| 000963 Stock Forecast | Huadong Medicine | Buy |
18
|
¥32.97 | Buy/Sell | ¥52.40 | 34.21% |
| 000513 Stock Forecast | Livzon Pharmaceutical Group | Outperform |
18
|
¥36.98 | Buy/Sell | ¥39.23 | 11.41% |
| 603456 Stock Forecast | Zhejiang Jiuzhou Pharmaceutica... | Buy |
18
|
¥16.11 | Buy/Sell | ¥37.79 | 46.55% |
.jpg)
Site Navigation
.jpg)